Ventricular tachycardia (V-tach) is a very serious condition that occurs when the ventricles are driven at high rates. The abnormal excitation pathways make ventricular contraction less synchronous resulting in less effective filling and emptying of the left ventricles. However, almost half of the V-tach alarms declared through processing of patterns observed in electrocardiography are not clinically actionable. The focus of this study is to provide guidance on determining whether a technically-correct V-tach alarm is clinically-actionable by determining its "hemodynamic impact". A supervisory learning approach based on conditional inference trees to determine the hemodynamic impact of a V-tach alarm based on extracted features is described. According to preliminary results on a subset of Multiparameter intelligent monitoring in intensive care II (MIMIC-II) database, true positive rate of more than 90% can be achieved.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC.2014.6944366DOI Listing

Publication Analysis

Top Keywords

ventricular tachycardia
8
v-tach alarm
8
hemodynamic-impact-based prioritization
4
prioritization ventricular
4
tachycardia alarms
4
alarms ventricular
4
v-tach
4
tachycardia v-tach
4
v-tach serious
4
serious condition
4

Similar Publications

Convergent procedure for long-standing persistent atrial fibrillation in heart failure with reduced ejection fraction.

Arch Cardiovasc Dis

December 2024

Service de cardiologie, hôpital Henri-Mondor, 94000 Créteil, France. Electronic address:

Background: Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with a significant reduction in morbimortality. The convergent procedure is a valid ablation option for the treatment of long-standing persistent atrial fibrillation.

Aim: To describe the outcomes of patients with heart failure with reduced ejection fraction and long-standing persistent atrial fibrillation who underwent the convergent procedure.

View Article and Find Full Text PDF

Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.

Front Cardiovasc Med

December 2024

Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Background: Women with heart failure with reduced ejection fraction (HFrEF) often experience worse clinical outcomes compared to men, including higher rates of mortality, hospitalization, and congestion. However, the effects of sacubitril/valsartan on these outcomes, as well as on ventricular tachyarrhythmias, have not been well studied in women with HFrEF.

Methods: This study included consecutive series of patients treated with sacubitril/valsartan at University Hospital Mannheim from 2016 to 2020.

View Article and Find Full Text PDF

Background: Charcot-Marie-Tooth is the most common inherited neuromuscular disorder. Rarely, it can be associated with heart failure and various arrhythmic disturbances. This case illustrates the challenges of making decisions to prevent sudden cardiac death in a patient with Charcot-Marie-Tooth disease.

View Article and Find Full Text PDF

Background: Left bundle branch block (LBBB) is a rare conduction disorder in athletes associated with ventricular dyssynchrony, which can lead to left ventricular systolic dysfunction and exercise intolerance. Inappropriate sinus tachycardia (IST) is characterized by an excessive heart rate (HR) that is not related to physiological needs, often resulting in reduced exercise capacity. Managing these conditions in athletes can be challenging, as standard treatments like beta-blockers and ivabradine, while effective in controlling HR, are described to be associated with a reduction in maximal exercise performance.

View Article and Find Full Text PDF

Background: Anomalous origin of the left coronary artery (LCA) from the pulmonary artery (PA) (ALCAPA) is a rare congenital abnormality. We present a case of an ALCAPA in a 25-year-old man.

Case Summary: A 25-year-old male with no past medical history was admitted to our intensive cardiac care unit after sudden cardiac arrest due to ventricular fibrillation and suspected acute coronary syndrome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!